Chimeric Therapeutics Limited

ASX:CHM Stock Report

Market Cap: AU$8.1m

Chimeric Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:CHM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Dec 23BuyAU$100,000Phillip HainsIndividual3,571,429AU$0.028

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CHM?
Owner TypeNumber of SharesOwnership Percentage
Private Companies17,500,0001.93%
Institutions39,276,1364.34%
Individual Insiders187,250,50520.7%
General Public661,123,20673%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.1%.


Top Shareholders

Top 15 shareholders own 26.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Paul Hopper
103,289,694AU$929.6k0%no data
2.39%
The Lind Partners, LLC
21,676,135AU$195.1k0%0.9%
1.94%
Zerrin Investments Pty Ltd, Asset Management Arm
17,600,001AU$158.4k0%15.14%
1.6%
Michael Stewart
14,500,000AU$130.5k0%no data
1.34%
Christine Brown
12,163,170AU$109.5k0%no data
1.33%
Valentino Fazio
12,000,000AU$108.0k0%no data
1.27%
Michael Barish
11,522,634AU$103.7k0%no data
1.14%
Phillip Hains
10,326,028AU$92.9k0%no data
1.1%
Su-Ming Wong
9,969,684AU$89.7k0%no data
0.99%
Syrax Investments Pty Ltd
9,000,000AU$81.0k0%no data
0.94%
Mbantua Holdings Pty Ltd
8,500,000AU$76.5k0%no data
0.47%
Eliot Bourk
4,230,603AU$38.1k0%no data
0.41%
Jenny Zhang
3,754,781AU$33.8k0%no data
0.41%
Tim Bensley
3,754,781AU$33.8k0%no data
0.19%
Lesley Russell
1,739,130AU$15.7k0%no data